Pharmafile Logo
Pharmafocus logo
Advanced Search

Denosumab approved for bone cancer use

November 19, 2010
Sales and Marketing Amgen, Cancer, Prolia, Xgeva, denosumab

Amgen’s denosumab has been approved in the US to prevent serious bone problems in patients with solid tumour cancers. Denosumab …

News

Natalie Lewis and Claire Nicholson join the Red Consultancy

November 19, 2010
Medical Communications Claire Nicholson, Natalie Lewis, appointment, medical communications, red consultancy, red health

The Red Consultancy has expanded its specialist health team, Red Health, with two new hires. Account director Natalie Lewis (pictured …

Appointment

CME Spotlight: Medical communications evolves

November 19, 2010
CME, CME Spotlight, Continuing medical education, Eugene Pozniak, medical education

I recently attended the first meeting of the MedComms Forum in Oxford. The venue of the Natural History Museum was …

Feature

New Men’s Health journal launched

November 19, 2010
Medical Communications Trends in Urology and Men's Health, medical education, men's health

A new controlled circulation journal Trends in Urology and Men’s Health has been launched to help promote doctors’ awareness of …

News

BTG to buy Biocompatibles

November 19, 2010
Research and Development BTG, Biocompatibles

BTG is to pay £156 million to acquire Biocompatibles, the drug-device specialists.Established in 1984 and floated in 1995, Biocompatibles specialises …

News

Synovate Healthcare appoints Dr Nicole Oehlrich

November 18, 2010
Medical Communications, Sales and Marketing Dr Nicole Oehlrich, appointment, medical communications, oncology market research, sales and marketing, synovate

Global market research agency Synovate has appointed Dr Nicole Oehlrich to the role of oncology business consultant for its specialist …

Appointment

Novartis outlines business strategy

November 18, 2010
Research and Development, Sales and Marketing Novartis, business development, pharma strategy

Novartis has outlined its long-term strategy for managing a number of key patent expiries. The Swiss-based pharma firm plans to …

News

European pharma expects regulatory compliance challenges

November 18, 2010
Sales and Marketing CRM, Cegedim Dendrite, Transparency Directive, regulatory compliance, transparency

European pharma companies will face major challenges over the next three years implementing new regulatory legislation and compliance requirements, according …

News

What would Mad Men make of the digital era?

November 18, 2010
Medical Communications Creative Lynx, advertising, digital marketing

Sharp-suited creative director Don Draper from AMC’s television series ‘Mad Men’, in conversation with Creative Lynx’s David Hunt … DAVID: …

Feature
Genzyme

Genzyme courting ‘white knight’ bid from Takeda

November 18, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, Takeda, pharma mergers

Genzyme is in talks with Takeda to secure a ‘white knight’ bid that would prevent Sanofi-Aventis from taking over the …

News

CP Pharma gets FDA warning for Wrexham facility

November 18, 2010
Manufacturing and Production CP Pharmaceuticals, FDA, FDA warning letter, Wockhardt, manufacturing compliance, pharma manufacturing

UK drugmaker CP Pharmaceuticals is the latest to receive a warning letter from the FDA for failing to meet standards …

News
2011 ABPI Code of Practice

New ABPI Code published

November 17, 2010
Medical Communications, Sales and Marketing 2011 ABPI Code, ABPI, ABPI Code of Practice, PMCPA, pharma marketing, pharma sales

The ABPI has published the 2011 version of its Code of Practice for UK pharmaceutical companies, with copies now available …

News

Government directs councils to supply personal health budgets

November 17, 2010
Sales and Marketing big society, government, healthcare, reforms

The government announced this week that it expects local councils to provide personal health budgets to a million eligible people …

News
Roche job cuts

Roche set to cut 4,800 jobs worldwide

November 17, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Jobs, Roche, avastin, cuts, taspoglutide

Roche’s ‘Operational Excellence’ programme will see it cut 6% of its global workforce over the next two years. The initiative …

News

Pfizer establishes new US research network

November 17, 2010
Research and Development, Sales and Marketing BiodiscoveryTherapeutics, MedImmune, Pfizer

Pfizer has established a new network of research partnerships with its Global Centers for Therapeutic Innovation. The Centers is a …

News

Government drops Dr Foster Intelligence

November 17, 2010
Sales and Marketing Dr Foster Intelligence, White paper, government, reforms

The government is set to drop the public-private partnership it currently has with Dr Foster Intelligence, its key provider information …

News

Europe’s neurologists unfamiliar with emerging Alzheimer’s drugs

November 17, 2010
Research and Development, Sales and Marketing Alzheimer's, Aricept, Decision Resources, Europe, Pfizer

A survey of neurologists in Europe has shown only a minority are aware of late stage drugs being developed to …

News
Big Blue Test

Digital Pharma: Diabetes video goes viral

November 16, 2010
Medical Communications, Sales and Marketing Diabetes Hands Foundation, Digital Pharma blog, Roche, diabetes, viral video, youtube

An online video encouraging diabetics to test their blood sugar levels has passed 117,000 views on YouTube in just over …

News

First patient treated in groundbreaking stem cell trial

November 16, 2010
Research and Development GRNOPC1, Geron, PISCES, Pilot Investigation of Stem Cells in Stroke, ReN001, ReNeuron, Stem cells, ischaemic stroke, stroke

The first patient has been treated in a groundbreaking stem cell trial as part of a bid to develop a …

News

FDA approves Eisai breast cancer drug Halaven

November 16, 2010
Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer

The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026